Figure 6.Distant metastasis-free survival between TKI alone and TKI+chemotherapy groups. (A) The unmatched cohort. (B) The propensity score matching cohort.
Figure 6 — Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer | Aging
